
Maryland Medical Cannabis Commission has approved the transfer of 100% of the ownership of Kind Therapeutics U.S.A., LLC, to MariMed Inc. (OTCQX:MRMD)
The approval was granted during the MMCC’s full commission meeting on April 13, 2022. The parties will now move forward to complete the closing of the transactions previously announced. Upon closing, Kind will become a wholly owned subsidiary of MariMed and its financials will be consolidated with MariMed’s in the company’s public filings.